Nasal adenocarcinoma induced by jaagsiekte sheep retrovirus in a juvenile goat: first report on pathological and molecular findings
Veterinary Research Communications · 2026-08 · 50 (4)
DOI: 10.1007/s11259-026-11272-7 ↗Kurz gefasst
Fallbericht in der Zeitschrift Veterinary Research Communications, online erschienen am 13.05.2026. Verfasst von Yesari Eroksuz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Veterinary Medicine, Firat University, Türkiye, 23200, Elazig, Turkey. yeroksuz@firat.edu.tr. Hauptthemen laut MEDLINE: Goat Diseases, Jaagsiekte sheep retrovirus, Nose Neoplasms, Adenocarcinoma. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fırat University.
Abstract (Originalsprache)
This study documents the first confirmed case of JSRV-associated nasal adenocarcinoma in a goat through a comprehensive analysis combining histopathological, immunohistochemical, and molecular techniques. An autopsy was conducted on a 12-month-old goat exhibiting progressive nasal obstruction. Tissue samples from the nasal mass were examined histologically using H&E staining. Immunohistochemical (IHC) analysis was performed to detect JSRV capsid protein expression and to assess cellular proliferation markers (Ki-67 and PCNA). Molecular screening via PCR was carried out using primers specific for JSRV, ENTV-1, ENTV-2. The JSRV-positive PCR amplicon was sequenced and subjected to phylogenetic analysis. PCR analysis confirmed the presence of JSRV proviral DNA (385 bp) in the tumor tissue, while results for ENTV-1 and ENTV-2 were negative. Histopathological examination identified a mixed glandular adenocarcinoma arising from the surface and glandular epithelium, with evidence of turbinate bone invasion. IHC revealed multifocal positivity for JSRV capsid antigen and indicated a high proliferation index (30–35%). Phylogenetic analysis classified the detected viral strain within the exogenous JSRV group. The infected goat originated from a herd with no documented contact with sheep. This case provides the first conclusive evidence of JSRV-induced nasal adenocarcinoma in a goat, indicating a potential expansion of the virus’s host and tissue tropism. These findings highlight the necessity for further investigation into the viral envelope-receptor interactions and promoter elements that govern JSRV tropism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Faculty of Veterinary Medicine, Firat University, Türkiye, 23200, Elazig, Turkey. yeroksuz@firat.edu.tr.
- Department of Virology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, 25240, Türkiye, Turkey.
- Department of Infection Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
- Department of Pathology, Faculty of Veterinary Medicine, Firat University, Türkiye, 23200, Elazig, Turkey.
Förderung
- Fırat University
Zitieren
APA
Eroksuz, Y., Timurkan, M. O., Berber, E., Karabulut, B., Kara, E., Bostan-Yoru, H., & Eroksuz, H. (2026). Nasal adenocarcinoma induced by jaagsiekte sheep retrovirus in a juvenile goat: first report on pathological and molecular findings. Veterinary Research Communications, 50(4). https://doi.org/10.1007/s11259-026-11272-7
Vancouver
Eroksuz Y, Timurkan MO, Berber E, Karabulut B, Kara E, Bostan-Yoru H, et al. Nasal adenocarcinoma induced by jaagsiekte sheep retrovirus in a juvenile goat: first report on pathological and molecular findings. Veterinary Research Communications. 2026;50(4). doi:10.1007/s11259-026-11272-7
BibTeX
@article{Eroksuz2026,
author = {Eroksuz, Yesari and Timurkan, Mehmet Ozkan and Berber, Engin and Karabulut, Burak and Kara, Emel and Bostan-Yoru, Hayrunnisa and Eroksuz, Hatice},
title = {Nasal adenocarcinoma induced by jaagsiekte sheep retrovirus in a juvenile goat: first report on pathological and molecular findings},
journal = {Veterinary Research Communications},
year = {2026},
volume = {50},
number = {4},
doi = {10.1007/s11259-026-11272-7}
}
EUVIMED